Bart Filius bought $231K of PRQR stock

Bart Filius, Dir of ProQR Therapeutics N.V. (PRQR), bought 150,000 shares of PRQR stock worth $231K, per an SEC Form 4 filed Jun 30, 2026.

It was an open-market purchase.

The trade happened on Jun 26, 2026, 4 days before it was made public.

PRQR has moved -11.1% since the trade date, from $1.53 to $1.36 (Nov 12, 2026 close).